Distressed High-Tech Opportunity : 3D Scanner

CONFIDENTIAL HIGH-TECH OPPORTUNITY
(Court-Supervised Asset Sale – France)

1. Transaction Overview
This opportunity concerns the acquisition of a high-potential preventive medicine / dermatology “scanner” project in the context of a court-supervised restructuring in France :-
- Court-supervised asset deal (French Commercial Court)
- Binding offers to be submitted within the court timetable – target closing in Q1 2026
- No employees to be taken over; lean structure and clean exit
- Strictly confidential – information memorandum and data room accessible upon signature of a NDA
Interested parties are invited to express interest as soon as possible given the constrained calendar.

2. Project Snapshot

Over 1.500 K€ has already been invested in the development of a cutting-edge technology intended to become a “scanner-type” device for : Preventive medicine, Dermatology, Adjacent wellness / aesthetic applications



3. Scope of Assets Included in the Sale
The contemplated transaction includes :
- European, Swiss and UK patents
- Registered designs & models
- Hardware & Industrial Assets
- Existing prototype (as is)
- Moulds used for manufacturing
- Small equipment, tooling and spare parts
- Complete digital platform: Website, Mobile applications, Embedded applications, Back-office system
- Social media accounts

The asset perimeter could be extended to include:
- Two additional strategic brands
- A second prototype

4. Debt & Liabilities
- No transfer of employees. Main Technologies are : Unity 3D, AWS, Python, Bubble (NoCode)
- The final allocation of liabilities, if any, will be defined in the context of the court-supervised process.

5. Investment & Financing Requirements

Purchase price for the assets (To be negotiated,) indicative benchmark: below €500k

Additional development & go-to-market budget:
Estimated at €2m to industrialize and launch the first commercial machine
The buyer is expected to have both:
Immediate availability of c. €500k (or equivalent) to fund the asset acquisition, and
The capacity to finance a further c. €2m (equity and/or debt) to complete development and market entry.

6. Process & Next Steps


- We are able to provide a restructuring scenario with a product vision, roadmap, etc.
- We can help you to create and formalize your offer for the French Court if aligned with the previous scenario


To streamline the process and comply with court requirements, interested parties are kindly requested to provide:
- Full contact details for the NDA: First name, Last name, Date and place of birth, Email address for e-signature, Phone number
- A brief statement of interest: Why this opportunity is of interest to you / your organization, Strategic fit with your existing activities (medical devices, dermatology, wellness, imaging, etc.)
- Financial capacity confirmations